Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements

Michael Charles Allwood, Donata Stonkute, Andrew Wallace, Alan-Shaun Wilkinson, Tim Hills, Conor Jamieson, on behalf of the BSAC Drug Stability Working Party, Mark Gilchrist, Mark Santillo, Andrew Seaton

10.1136/ejhpharm-2018-001515

September 18, 2018

Incidence and prevalence of intravenous medication errors in the UK: a systematic review

Adam Sutherland, Michela Canobbio, Janine Clarke, Michelle Randall, Tom Skelland, Emma Weston

10.1136/ejhpharm-2018-001624

October 23, 2018

Impact of a pharmaceutical care programme for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: a randomised controlled trial

Ana Juanes, Noe Garin, Maria Antonia Mangues, Sergio Herrera, Mireia Puig, Maria Jose Faus, Maria Isabel Baena

10.1136/ejhpharm-2016-001055

February 23, 2017

Editor's choice

Furosemide ethanol-free oral solutions for paediatric use: formulation, HPLC method and stability study

Lukáš Zahálka, Sylva Klovrzová, Ludmila Matysová, Zdenka Šklubalová, Petr Solich

10.1136/ejhpharm-2017-001264

August 2, 2017

Editor's choice

Adverse-event management and reporting for electronic cigarettes (e-cigarettes)

Ravina Barrett

10.1136/ejhpharm-2018-001747

October 9, 2018

Brexit and shortages

Pascal Garel

10.1136/ejhpharm-2018-001739

October 25, 2018

Formulation and compatibility studies are important

Phil Wiffen

10.1136/ejhpharm-2018-001727

September 16, 2018

Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis

Robert Janknegt, Marieke van den Beuken, Sjouke Schiere, Michael Überall, Roger Knaggs, Jaquie Hanley, Morten Thronaes

10.1136/ejhpharm-2016-001127

January 11, 2017

Trastuzumab infusion reactions in breast cancer. Should we routinely observe after the first dose?

L Price, A M Brunt

10.1136/ejhpharm-2016-001155

March 16, 2017

Physical compatibility of MCT/LCT propofol emulsions with crystalloids during simulated Y-site administration

Gábor Szalai, Gábor Katona, Mária Matuz, Orsolya Jójárt-Laczkovich, Péter Doró

10.1136/ejhpharm-2017-001374

January 18, 2018

Editor's choice